ALK-Abelló
ALK-Abelló A/S (Nasdaq Copenhagen: ALK B), also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world’s largest makers of allergy immunotherapy products (also known as ‘allergy vaccines’) with 81% of its revenue coming from sales in Europe.
Wikipage disambiguates
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
ALK-Abelló
ALK-Abelló A/S (Nasdaq Copenhagen: ALK B), also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world’s largest makers of allergy immunotherapy products (also known as ‘allergy vaccines’) with 81% of its revenue coming from sales in Europe.
has abstract
ALK-Abelló (OMX : ALK B), plus ...... d’affaires réalisé en Europe.
@fr
ALK-Abelló A/S (Nasdaq Copenha ...... e coming from sales in Europe.
@en
founding year
industry
key person
location
number of employees
revenue ($)
type
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
999,656,795
Link from a Wikipage to another Wikipage
foundation
homepage
industry
Pharmaceuticals
@en
key people
Carsten Hellmann (CEO)
@en
Steen Riisgaard (Chairman)
@en
Location
Hørsholm, Denmark
@en
logo
@en
name
ALK-Abelló A/S
@en
num employees
products
Acarizax, Grazax, SlitOneUltra, Alutard SQ, Jext
@en
revenue
DKK 3,005 million
@en
type
wikiPageUsesTemplate
subject
hypernym
comment
ALK-Abelló (OMX : ALK B), plus ...... d’affaires réalisé en Europe.
@fr
ALK-Abelló A/S (Nasdaq Copenha ...... e coming from sales in Europe.
@en
label
ALK-Abelló
@en
ALK-Abelló
@fr
wasDerivedFrom
homepage
isPrimaryTopicOf
name
ALK-Abelló A/S
@en